Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia
NCT06020495Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desmopressin in hyponatremia, sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2024; status: recruiting.
02
Drugs
desmopressin
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT06020495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06020495.